(+)-dexrazoxane multiple interactions ISO RGD:10163 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of SLC25A5 mRNA CTD PMID:26873546 (1->4)-beta-D-glucan multiple interactions ISO RGD:10163 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A5 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:10163 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC25A5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10163 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A5 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:732042 6480464 Dinitrochlorobenzene binds to SLC25A5 protein CTD PMID:32991956 17alpha-ethynylestradiol affects expression ISO RGD:10163 6480464 Ethinyl Estradiol affects the expression of SLC25A5 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:10163 6480464 Ethinyl Estradiol results in increased expression of SLC25A5 mRNA CTD PMID:16174780 more ... 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLC25A5 mRNA CTD PMID:16174780 , PMID:19400957 17alpha-ethynylestradiol multiple interactions ISO RGD:10163 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A5 mRNA, fulvestrant inhibits the reaction [Ethinyl Estradiol results in increased expression of SLC25A5 mRNA] CTD PMID:16467188 , PMID:17942748 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of SLC25A5 protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10163 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10163 6480464 Tetrachlorodibenzodioxin affects the expression of SLC25A5 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10163 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC25A5 mRNA CTD PMID:16467188 , PMID:17942748 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC25A5 mRNA CTD PMID:24780913 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of SLC25A5 mRNA CTD PMID:8554334 acrolein multiple interactions ISO RGD:732042 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC25A5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC25A5 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC25A5 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:732042 6480464 Aflatoxin B1 results in increased expression of SLC25A5 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:732042 6480464 Aflatoxin B1 results in decreased methylation of SLC25A5 gene CTD PMID:27153756 all-trans-acitretin decreases expression EXP 6480464 Acitretin results in decreased expression of SLC25A5 protein CTD PMID:23384448 alpha-pinene multiple interactions ISO RGD:732042 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC25A5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SLC25A5 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC25A5 mRNA CTD PMID:16483693 aniline increases expression ISO RGD:10163 6480464 aniline results in increased expression of SLC25A6 mRNA CTD PMID:22016648 antirheumatic drug decreases expression ISO RGD:732042 6480464 Antirheumatic Agents results in decreased expression of SLC25A5 mRNA CTD PMID:24449571 arsenite(3-) multiple interactions ISO RGD:732042 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SLC25A5 protein], arsenite promotes the reaction [G3BP1 protein binds to SLC25A5 mRNA] CTD PMID:32406909 Atractyloside decreases activity ISO RGD:732042 6480464 Atractyloside results in decreased activity of SLC25A5 protein CTD PMID:26746582 atrazine increases expression ISO RGD:732042 6480464 Atrazine results in increased expression of SLC25A5 mRNA CTD PMID:22378314 azoxystrobin increases expression ISO RGD:732042 6480464 azoxystrobin results in increased expression of SLC25A5 mRNA CTD PMID:33512557 benzo[a]pyrene multiple interactions ISO RGD:10163 6480464 AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of SLC25A5 mRNA] CTD PMID:15034205 benzo[a]pyrene increases methylation ISO RGD:732042 6480464 Benzo(a)pyrene results in increased methylation of SLC25A5 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:10163 6480464 Benzo(a)pyrene results in increased expression of SLC25A5 mRNA CTD PMID:15034205 bisphenol A multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in decreased expression of SLC25A5 protein CTD PMID:26930160 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC25A5 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:10163 6480464 bisphenol A results in increased expression of SLC25A5 mRNA CTD PMID:33221593 , PMID:35479511 bisphenol A increases expression ISO RGD:732042 6480464 bisphenol A results in increased expression of SLC25A5 protein CTD PMID:33376534 bisphenol A decreases expression ISO RGD:732042 6480464 bisphenol A results in decreased expression of SLC25A5 mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:732042 6480464 bisphenol A affects the expression of SLC25A5 mRNA CTD PMID:30903817 bisphenol A affects expression ISO RGD:10163 6480464 bisphenol A affects the expression of SLC25A5 mRNA CTD PMID:26063408 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of SLC25A5 protein CTD PMID:25933445 bongkrekic acid decreases activity ISO RGD:732042 6480464 Bongkrekic Acid results in decreased activity of SLC25A5 protein CTD PMID:26746582 cadmium atom decreases expression ISO RGD:732042 6480464 Cadmium results in decreased expression of SLC25A5 mRNA CTD PMID:24376830 carbon nanotube increases expression ISO RGD:10163 6480464 Nanotubes more ... CTD PMID:25554681 Carboxyatractyloside decreases activity ISO RGD:732042 6480464 carboxyatractyloside results in decreased activity of SLC25A5 protein CTD PMID:26746582 chloropicrin affects expression ISO RGD:732042 6480464 chloropicrin affects the expression of SLC25A5 mRNA CTD PMID:26352163 clobetasol increases expression ISO RGD:10163 6480464 Clobetasol results in increased expression of SLC25A5 mRNA CTD PMID:27462272 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of SLC25A5 mRNA CTD PMID:8554334 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of SLC25A5 mRNA CTD PMID:17602206 closantel decreases activity ISO RGD:732042 6480464 closantel results in decreased activity of SLC25A5 protein CTD PMID:26746582 copper(II) sulfate decreases expression ISO RGD:732042 6480464 Copper Sulfate results in decreased expression of SLC25A5 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:732042 6480464 Cyclosporine results in decreased expression of SLC25A5 mRNA CTD PMID:20106945 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SLC25A5 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:10163 6480464 Dibutyl Phthalate results in increased expression of SLC25A5 mRNA CTD PMID:17361019 , PMID:21266533 disodium selenite increases expression ISO RGD:732042 6480464 Sodium Selenite results in increased expression of SLC25A5 mRNA CTD PMID:18175754 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC25A5 mRNA CTD PMID:21551480 dopamine increases expression ISO RGD:732042 6480464 Dopamine results in increased expression of SLC25A5 protein CTD PMID:24675778 doxorubicin multiple interactions ISO RGD:10163 6480464 [Doxorubicin co-treated with Dexrazoxane] results in decreased expression of SLC25A5 mRNA CTD PMID:26873546 doxorubicin increases expression ISO RGD:732042 6480464 Doxorubicin results in increased expression of SLC25A5 mRNA CTD PMID:29803840 doxorubicin affects expression ISO RGD:732042 6480464 Doxorubicin affects the expression of SLC25A5 protein CTD PMID:29385562 doxorubicin increases expression ISO RGD:10163 6480464 Doxorubicin results in increased expression of SLC25A6 mRNA CTD PMID:22016648 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC25A5 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:10163 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A5 mRNA CTD PMID:22206623 fonofos increases methylation ISO RGD:732042 6480464 Fonofos results in increased methylation of SLC25A5 promoter CTD PMID:22847954 fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in decreased expression of SLC25A5 protein CTD PMID:26930160 fulvestrant multiple interactions ISO RGD:10163 6480464 fulvestrant inhibits the reaction [Ethinyl Estradiol results in increased expression of SLC25A5 mRNA] CTD PMID:16467188 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC25A5 mRNA CTD PMID:22061828 hydralazine multiple interactions ISO RGD:732042 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC25A5 mRNA CTD PMID:17183730 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of SLC25A5 mRNA CTD PMID:24349266 inulin multiple interactions ISO RGD:10163 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC25A5 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:732042 6480464 Ivermectin results in decreased expression of SLC25A5 protein CTD PMID:32959892 menadione affects expression ISO RGD:732042 6480464 Vitamin K 3 affects the expression of SLC25A5 mRNA CTD PMID:20044591 methidathion increases expression ISO RGD:10163 6480464 methidathion results in increased expression of SLC25A5 mRNA CTD PMID:34813904 miconazole increases expression ISO RGD:10163 6480464 Miconazole results in increased expression of SLC25A5 mRNA CTD PMID:27462272 N-methyl-4-phenylpyridinium increases expression ISO RGD:732042 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC25A5 protein CTD PMID:24675778 ozone multiple interactions ISO RGD:732042 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SLC25A5 mRNA more ... CTD PMID:32699268 ozone increases expression EXP 6480464 Ozone results in increased expression of SLC25A5 mRNA CTD PMID:35737395 paracetamol increases expression ISO RGD:10163 6480464 Acetaminophen results in increased expression of SLC25A5 protein CTD PMID:21329376 paracetamol increases expression ISO RGD:732042 6480464 Acetaminophen results in increased expression of SLC25A5 mRNA CTD PMID:25704631 parathion increases methylation ISO RGD:732042 6480464 Parathion results in increased methylation of SLC25A5 promoter CTD PMID:22847954 pentachlorophenol increases expression ISO RGD:10163 6480464 Pentachlorophenol results in increased expression of SLC25A5 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of SLC25A5 mRNA CTD PMID:20136073 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10163 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC25A5 mRNA more ... CTD PMID:36331819 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of SLC25A5 mRNA CTD PMID:15215175 picoxystrobin increases expression ISO RGD:732042 6480464 picoxystrobin results in increased expression of SLC25A5 mRNA CTD PMID:33512557 puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [cadmium acetate results in decreased expression of SLC25A5 mRNA], puerarin inhibits the reaction [cadmium acetate results in decreased expression of SLC25A5 protein] CTD PMID:27717697 pyrimidifen increases expression ISO RGD:732042 6480464 pyrimidifen results in increased expression of SLC25A5 mRNA CTD PMID:33512557 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of SLC25A5 mRNA CTD PMID:17103110 resveratrol increases expression ISO RGD:10163 6480464 resveratrol results in increased expression of SLC25A5 protein CTD PMID:25505154 rotenone increases expression ISO RGD:732042 6480464 Rotenone results in increased expression of SLC25A5 mRNA CTD PMID:33512557 sodium arsenite increases expression ISO RGD:732042 6480464 sodium arsenite results in increased expression of SLC25A5 mRNA CTD PMID:34032870 sodium fluoride decreases expression ISO RGD:10163 6480464 Sodium Fluoride results in decreased expression of SLC25A5 protein CTD PMID:27548804 stavudine increases expression EXP 6480464 Stavudine results in increased expression of SLC25A5 mRNA CTD PMID:18299183 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of SLC25A5 protein] CTD PMID:19634143 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of SLC25A5 protein CTD PMID:19634143 sulfasalazine increases expression ISO RGD:10163 6480464 Sulfasalazine results in increased expression of SLC25A6 mRNA CTD PMID:22016648 tamoxifen affects expression ISO RGD:10163 6480464 Tamoxifen affects the expression of SLC25A5 mRNA CTD PMID:17555576 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of SLC25A5 mRNA CTD PMID:19400957 tamoxifen increases expression ISO RGD:10163 6480464 Tamoxifen results in increased expression of SLC25A5 mRNA CTD PMID:19400957 terbufos increases methylation ISO RGD:732042 6480464 terbufos results in increased methylation of SLC25A5 promoter CTD PMID:22847954 tetrachloromethane affects expression ISO RGD:10163 6480464 Carbon Tetrachloride affects the expression of SLC25A5 mRNA CTD PMID:17484886 tolcapone affects binding EXP 6480464 tolcapone binds to SLC25A5 protein CTD PMID:19783845 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SLC25A5 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:10163 6480464 trimellitic anhydride results in increased expression of SLC25A5 mRNA CTD PMID:19042947 tungsten increases expression ISO RGD:10163 6480464 Tungsten results in increased expression of SLC25A5 mRNA CTD PMID:30912803 ursodeoxycholic acid affects expression ISO RGD:732042 6480464 Ursodeoxycholic Acid affects the expression of SLC25A5 mRNA CTD PMID:18422935 valproic acid multiple interactions ISO RGD:732042 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC25A5 mRNA CTD PMID:17183730 valproic acid affects expression ISO RGD:10163 6480464 Valproic Acid affects the expression of SLC25A5 mRNA CTD PMID:17963808 valproic acid increases methylation ISO RGD:732042 6480464 Valproic Acid results in increased methylation of SLC25A5 gene CTD PMID:29154799